AUPH Q3 2018 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$375,000+1193.1% YoY

Gross Profit

-$11M-2873.9% margin

Operating Income

-$14M-3762.1% margin

Net Income

-$18M-4891.2% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+1193.1%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$158M

Total Liabilities

$32M

Stockholders' Equity

$125M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$375,000	$29,000	+1193.1%
Gross Profit	-$11M	-$11M	+0.0%
Operating Income	-$14M	-$14M	-2.3%
Net Income	-$18M	-$13M	-39.8%